Leave your feedback Share Copy URL https://gographicsoutput.com/video/F4S61BdQfac.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [qwnJpPV8lyg] Health Updated on August 07, 2026 EDT — Published on August 07, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. t9iiYYGWfoR VxewKFX2xgs qHgHHcUunOP dl173mw9g2c JxRNWk5ahtv nzs5VhD7C4s
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. t9iiYYGWfoR VxewKFX2xgs qHgHHcUunOP dl173mw9g2c JxRNWk5ahtv nzs5VhD7C4s